The National Health Surveillance Agency (ANVISA) has opened registration for the Cadifa 2026 Seminar, an important event bringing together professionals and experts in pharmaceutical regulatory affairs.
The seminar represents a space for dialogue and updates on matters related to pharmaceutical procedures and regulations in Brazil. Cadifa, which stands for Chamber of Pharmacovigilance Directors, regularly organizes meetings to discuss relevant topics in the pharmaceutical segment.
The event provides participants with an opportunity to learn about the latest regulatory updates, share experiences, and establish networking with other professionals in the pharmaceutical industry. Professionals from various areas, ranging from pharmacovigilance to regulatory affairs, can benefit from the program content.
Registration is now available on the ANVISA website, allowing interested parties to secure their participation in this edition. The seminar offers an excellent opportunity for pharmaceutical companies, consultants, and compliance and regulatory affairs professionals to stay updated with the main demands of the sector.
This type of initiative reinforces ANVISA's commitment to transparency and communication with pharmaceutical sector stakeholders, promoting constructive discussions on regulation and health surveillance.
